Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Thomas Möhler"'
Autor:
Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Messner, Anja Seckinger, Axel Benner, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Jens Hillengass, Uta Bertsch, Kai Neben, Thomas Möhler, Jean François Rossi, Anna Jauch, Bernard Klein, Hartmut Goldschmidt
Publikováno v:
Haematologica, Vol 96, Iss 1 (2011)
Background Proliferation of malignant plasma cells is a strong adverse prognostic factor in multiple myeloma and simultaneously targetable by available (e.g. tubulin polymerase inhibitors) and upcoming (e.g. aurora kinase inhibitors) compounds.Design
Externí odkaz:
https://doaj.org/article/4bff6fb7a2514ee8820850615ab98817
Autor:
Dirk Hose, Bernard Klein, Hartmut Goldschmidt, Kai Neben, Thomas Möhler, Thomas Hielscher, Thierry Rème, Anja Seckinger, Tobias Meißner
PDF file - 131K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b3531d525e7b02cdb505c1f837dfdd
https://doi.org/10.1158/1078-0432.22443582.v1
https://doi.org/10.1158/1078-0432.22443582.v1
Autor:
Dirk Hose, Bernard Klein, Hartmut Goldschmidt, Kai Neben, Thomas Möhler, Thomas Hielscher, Thierry Rème, Anja Seckinger, Tobias Meißner
XLS file - 99K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93490a675371a709a130bda0b7dd325
https://doi.org/10.1158/1078-0432.22443576.v1
https://doi.org/10.1158/1078-0432.22443576.v1
Autor:
Dirk Hose, Bernard Klein, Hartmut Goldschmidt, Kai Neben, Thomas Möhler, Thomas Hielscher, Thierry Rème, Anja Seckinger, Tobias Meißner
PDF file - 885K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315f834f6d2ee65ef5ef284737ea9fbb
https://doi.org/10.1158/1078-0432.22443579
https://doi.org/10.1158/1078-0432.22443579
Autor:
Dirk Hose, Bernard Klein, Hartmut Goldschmidt, Kai Neben, Thomas Möhler, Thomas Hielscher, Thierry Rème, Anja Seckinger, Tobias Meißner
Purpose: Multiple myeloma is an incurable malignant plasma cell disease characterized by survival ranging from several months to more than 15 years. Assessment of risk and underlying molecular heterogeneity can be excellently done by gene expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e44292cae0049f27d5b00cbb50ff3b
https://doi.org/10.1158/1078-0432.c.6519879.v1
https://doi.org/10.1158/1078-0432.c.6519879.v1
Autor:
Thomas Möhler, Thomas M. Proebstle
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 3:265-269
Objective Endothermal ablation has become a commonly used technology for occlusion of refluxing great saphenous veins (GSVs). However, the risk for primarily untreated accessory saphenous veins (ASVs) to develop reflux during follow-up has not yet be
Autor:
Martin Vogel, Hans Salwender, Niels Weinhold, Manuela Hummel, Martin Hoffmann, Barbara Huegle-Doerr, Ullrich Graeven, K Dembowsky, Anna Jauch, M. Hänel, J Nickel, Jan Dürig, Ralf Angermund, Katja Weisel, Stefanie Huhn, P Reimer, Thomas Hielscher, Patrick Wuchter, Igor Wolfgang Blau, Uta Bertsch, F Lordick, Maria Pritsch, H Kirchner, H. Goldschmidt, M Görner, N Peter, Thomas Möhler
Publikováno v:
Bone Marrow Transplantation
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab99584f2dfb45250e09d4482344c4b3
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85019200614
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85019200614
Autor:
Thomas M. Proebstle, Thomas Möhler, Oliver Goeckeritz, Jose I. Almeida, Bettina Kleis-Fischer, Ian J. Franklin
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 6:41-47.e1
The objective of this study was to evaluate the feasibility and safety of a polyglycolic acid (PGA) yarn implant for nonthermal ablation of saphenous vein reflux.In two consecutive cohort studies (TAHOE I and TAHOE II), the feasibility of abolition o
Autor:
Thomas M. Proebstle, Thomas Möhler
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 4:380-381
Publikováno v:
Anti-Cancer Drugs. 14:515-522
It is well established that certain chemotherapeutic agents have potent antiangiogenic properties which may be part of their antitumor activity. Temozolomide (TMZ) is a lipophilic methylating agent used in the therapy of malignant melanoma and other